different glp 1 injections The Rise of GLP-1 Medications – Magnet GLP-1 Agonists are commonly used

Early, in-depth review article that evaluates the similarities and differences between short-acting and long-acting GLP-1R agonists in terms of glucose-lowering efficacy and adverse effects, and discusses the possibilities for utilizing these agents for individualized treatment of T2DM

January 2025: Ozempics warning label was updated to include severe pancreatitis and kidney injuries

In our study, L-carnitine infusion not only ameliorated the sensation of hunger, but improved fatigue with significant weight loss during the modified fasting period

In rats, Anamorelin (3-30 mg/kg) significantly and dose-dependently increases food intake and body weight

Are certain bacterial strains predictive of long-term weight maintenance

Stroke 34(3):688694